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Introduction. In patients with extra-adrenal malignancy, an adrenal mass necessitates investigating the possibility of metastatic
tumor. Curable adrenal metastasis are considered as a rare event. Case report. A 52-year-old male suﬀering from lower esophageal
adenocarcinomawithasolitaryleftadrenalmetastasisispresentedherein,whounderwentconcomitanttranshiatalesophagectomy
and left adrenalectomy. The patient remains disease-free 18 months later. Discussion. Adrenal metastases mostly occur in patients
with lung, kidney, breast, and gastrointestinal carcinomas. Primary esophageal adenocarcinoma gives adrenal metastatic deposits
according to autopsy series with an incidence of about 3%–12%. When no other evidence of metastatic disease in cancer patients
exists, several authors advocate adrenalectomy with curative intent. Isolated cases of long-term survival after resection of solitary
adrenal metastasis from esophageal adenocarcinoma, like in our case, have been reported only as case reports. Conclusion. This
study concludes that surgical resection may result in survival beneﬁt in selected patients with solitary adrenal metastasis from
esophageal adenocarcinoma.
1.Introduction
In patients with extra-adrenal malignancy, staging imaging
modalities frequently reveal adrenal masses and require
exclusion of the possibility of metastatic tumor spread [1].
Adrenal metastatic tumor usually indicates advanced malig-
nancy and disseminated disease for most cancer patients,
and especially for patients with primary esophageal cancer
[2]. Rarely, radical surgical resection of the primary tumor
associated with excision of the adrenal metastasis results in
long-term survival. We present herein a case of a 52-year-
old male suﬀering from esophageal adenocarcinoma with
solitary metastasis to the left adrenal gland treated with
concomitant transhiatal esophagectomy and left adrenalec-
tomy.Inhisfollow-upvisits,heremainsdisease-freeeighteen
months later. A short review of the literature with reference
to similar cases is also attempted.
2.Casereport
A 52-year-old male presented complaining of dysphagia
in both solid food and liquids for the last ﬁfteen days.
Esophagogastroduodenoscopy (EGD) revealed a solid mass
narrowing the esophageal lumen on the lower third of the
esophagus (Figure 1). Histopathological results, from EGD
biopsy, demonstrated a moderately diﬀerentiated adenocar-
cinoma of the esophagus, growing on Barrett’s esophagus
background lesion. Staging computed tomography scan
(CT-scan) of the thorax and the abdomen revealed a
2 × 2.5cm mass lesion of the left adrenal gland, having
suspiciousimagingcharacteristics.TumormarkerswereCEA
55mlU/mL and Ca 19–9 854IU/mL. The patient was ﬁt
for major surgery, and palliative operative approach was
decidedduetopossibledisseminateddisease.Thepresenceof
a pheochromocytoma was excluded measuring urine vinyl-
mandelic acid (VMA) levels, which were normal. Concomi-
tant transhiatal esophagectomy and left adrenalectomy was
performed,andanuneventfulpostoperativecoursefollowed.
The patient was discharged on the 16th postoperative day,
because of postoperative pneumonia, which was treated
withintravenousantibiotics.Pathologicalexaminationofthe
esophagus conﬁrmed the diagnosis and showed extensive
adenocarcinoma inﬁltrating the esophageal wall and 4 out
of 6 local lymph nodes positive for metastatic disease. The2 Case Reports in Medicine
Table 1: Adrenalectomy for metastatic disease in case reports.
Authors Cancer primary site No. of patients Survival
Katayama et al. [8] Colorectal 1 3 years and 5 months
Branum et al. [9] Melanoma 8 Mean survival: 59 months
Fumagalli et al. [10] Esophagogastric junction adenocarcinoma 5 3 long-term survivals
Mokuno et al. [11] Gastric adenocarcinoma 1 40 months (bilateral
adrenalectomy)
Saito et al. [12] Esophageal adenocarcinoma 1 5 years and 11 months (he
died of another reason)
Figure 1: Endoscopy indicating a solid mass (arrow) narrowing the
esophageal lumen.
Figure 2: Histological section of the adrenal cortex showing
extensive inﬁltration (arrows) by glandular structures (H-E, ×200).
positive lymph nodes were paraesophageal 1cm away from
the primary lesion. Also, the adrenal gland was inﬁltrated
by the same adenocarcinoma measuring 3cm in diameter
(Figure 2). In his follow-up visits, the patient remains
disease-free eighteen months later.
3. Discussion
An adrenal mass lesion can represent multiple pathologic
entities, benign or malignant. Most of these lesions are
simple adenomas or secondary metastatic tumors [1].
Adrenal metastases mostly occur in patients with lung,
kidney, breast, and gastrointestinal carcinomas, and rarely,
melanoma or lymphoma and leuykemia involve the adrenals
[3]. These lesions are frequently encountered during autopsy
but uncommonly present clinically and are revealed during
staging evaluation of a cancer patient using tomographic
imaging modalities. Primary esophageal adenocarcinoma
gives adrenal metastatic deposits quite frequently according
to autopsy series with an incidence of about 3%–12% [3,
4], via hematogenous or lymphatic routes, and indicates
disseminated disease. However, a solitary synchronous or
metachronous metastasis for primary esophageal adenocar-
cinoma, like in our case, is a rare event, which confronts
the physician to a therapeutic dilemma. In general, when
no other evidence of metastatic disease in cancer patients
exists, several authors advocate adrenalectomy with curative
intentandprovideevidencethataggressivesurgicalapproach
prolongs survival [5–7]. Although it is not an established
principle in surgical oncology, concomitant primary tumor
resection and adrenalectomy for metastatic disease has been
reported for various cancer types in case reports [5–9].
Table 1 summarizes case reports similar to our case. More
speciﬁcally, Fumagalli et al. analyzing 102 patients with
esophagogastric adenocarcinoma found 5 patients suﬀering
synchronous or metachronous adrenal metastasis and report
better survival rates for surgical resection as long as the
gland is the only site of metastasis beyond lymphonodal
disease [10]. A Japanese study, also, reported long-term
survival after resection for adrenal metastases from gastric
cancer [11]. Also, isolated cases of long term survival after
resection of solitary adrenal metastasis from esophageal
adenocarcinoma, like in our case, have been reported only as
casereports[12].Inourcase,althoughthemoreconservative
approach, regarding lymph-node dissection, of transhiatal
esophagectomy was performed assuming microscopically
disseminating disease, indicated by the adrenal metastasis,
the patient remained disease free for long term interval. It
is indicated from the above that in the absence of large
case series for this rare clinical event, long-term disease-
free survival even in case reports justiﬁes aggressive surgical
procedures in generally ﬁt patients.
4. Conclusion
The management of a solitary adrenal metastasis in cancer
patients can present as a surgical dilemma. This study
concludes that surgical resection may result in survival
beneﬁt in selected patients with solitary adrenal metastasis
from esophageal adenocarcinoma and should be considered
as a therapeutic option.Case Reports in Medicine 3
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